Top 100 Contractors in NAICS 325: Chemical Manufacturing, FY2021

Parent companies by net contract obligations Oct 1, 2020 – Sep 30, 2021 Code page on GovTribe

The top 10 won 92% of FY2021 NAICS 325 contract dollars

Ranking facts

Contract obligations
$57,394,873,147 Net of deobligations, by contracts coded NAICS 325 or a code under it
Contractors
2,234 Parent companies with an obligation
Largest contractor
Pfizer Inc. $23.1 billion, 39.5% of obligations
Data as of

Contract actions from FPDS (SAM.gov). How the rankings work · Download all 100 rows as CSV

Full ranking

Rank Contractor Net obligations Share Trend
1 $23,135,362,935
Rank history: #1 in FY2022, #2 in FY2023 and not on the FY2024–FY2025 lists; up 30 since FY2020.
2 $11,700,888,945
Rank history: #2 in FY2022, #1 in FY2023, #1 in FY2024 and #1 in FY2025; down 1 since FY2020.
3 $7,363,802,587
Rank history: #4 in FY2022, #33 in FY2023 and not on the FY2024–FY2025 lists; down 1 since FY2020.
4 $5,565,148,165
Rank history: not on the FY2022–FY2025 lists; new, not ranked in FY2020.
5 $1,913,730,016
Rank history: #3 in FY2022 and not on the FY2023–FY2025 lists; new, not ranked in FY2020.
6 $1,663,247,245
Rank history: #5 in FY2022, #8 in FY2023 and not on the FY2024–FY2025 lists; up 12 since FY2020.
7 $1,313,638,023
Rank history: #8 in FY2022 and not on the FY2023–FY2025 lists; up 459 since FY2020.
8 $515,938,382
Rank history: #14 in FY2022, #4 in FY2023, #2 in FY2024 and #2 in FY2025; down 4 since FY2020.
9 $287,673,486
Rank history: #7 in FY2022, not on the FY2023 list, #24 in FY2024 and #38 in FY2025; down 2 since FY2020.
10 $257,359,270
Rank history: #20 in FY2022, #10 in FY2023 and not on the FY2024–FY2025 lists; down 1 since FY2020.
11 $214,573,577
Rank history: #12 in FY2022 and not on the FY2023–FY2025 lists; down 6 since FY2020.
12 $162,082,167
Rank history: not on the FY2022–FY2025 lists; up 183 since FY2020.
13 $157,193,984
Rank history: #21 in FY2022, #20 in FY2023, #32 in FY2024 and not on the FY2025 list; down 3 since FY2020.
14 $127,944,659
Rank history: #19 in FY2022, #16 in FY2023, #14 in FY2024 and #13 in FY2025; unchanged since FY2020.
15 $126,000,000
Rank history: not on the FY2022–FY2025 lists; new, not ranked in FY2020.
16 $123,120,000
Rank history: not on the FY2022–FY2024 lists and #67 in FY2025; new, not ranked in FY2020.
17 $95,497,600
Rank history: #15 in FY2022, #17 in FY2023, #9 in FY2024 and #9 in FY2025; down 2 since FY2020.
18 $86,460,801
Rank history: #55 in FY2022, #66 in FY2023 and not on the FY2024–FY2025 lists; down 12 since FY2020.
19 $81,652,943
Rank history: #18 in FY2022, #15 in FY2023, #38 in FY2024 and #32 in FY2025; up 16 since FY2020.
20 $81,142,412
Rank history: #16 in FY2022, #5 in FY2023, #57 in FY2024 and not on the FY2025 list; down 1 since FY2020.
21 $79,896,354
Rank history: #10 in FY2022, #13 in FY2023 and not on the FY2024–FY2025 lists; up 57 since FY2020.
22 $70,002,309
Rank history: #13 in FY2022, #26 in FY2023 and not on the FY2024–FY2025 lists; new, not ranked in FY2020.
23 $69,300,000
Rank history: not on the FY2022–FY2025 lists; new, not ranked in FY2020.
24 $67,831,072
Rank history: #80 in FY2022, #30 in FY2023 and not on the FY2024–FY2025 lists; up 37 since FY2020.
25 $63,612,248
Rank history: not on the FY2022–FY2025 lists; new, not ranked in FY2020.
26 $61,567,403
Rank history: #30 in FY2022, #43 in FY2023, #35 in FY2024 and #43 in FY2025; down 3 since FY2020.
27
Sicpa Holding SA Through Sicpa Securink Corp
$59,792,792
Rank history: #25 in FY2022, #44 in FY2023, #42 in FY2024 and not on the FY2025 list; up 13 since FY2020.
28 $54,227,528
Rank history: not on the FY2022–FY2025 lists; up 67 since FY2020.
29 $53,538,814
Rank history: #50 in FY2022, #76 in FY2023, #45 in FY2024 and not on the FY2025 list; up 20 since FY2020.
30 $50,027,140
Rank history: #47 in FY2022 and not on the FY2023–FY2025 lists; new, not ranked in FY2020.
31 $49,668,750
Rank history: #24 in FY2022, #22 in FY2023, #20 in FY2024 and #15 in FY2025; down 6 since FY2020.
32 $48,494,279
Rank history: #66 in FY2022, #27 in FY2023 and not on the FY2024–FY2025 lists; up 15 since FY2020.
33 $42,980,395
Rank history: #27 in FY2022, #64 in FY2023 and not on the FY2024–FY2025 lists; up 9 since FY2020.
34 $41,428,553
Rank history: #28 in FY2022, #12 in FY2023, #13 in FY2024 and #14 in FY2025; unchanged since FY2020.
35 $41,324,092
Rank history: #40 in FY2022, #25 in FY2023 and not on the FY2024–FY2025 lists; down 2 since FY2020.
36 $40,121,477
Rank history: not on the FY2022–FY2025 lists; down 15 since FY2020.
37
Teva Pharmaceutical Industries Ltd. 2 awardees, including Teva Pharmaceuticals Usa, Inc.
$39,889,900
Rank history: #43 in FY2022, #40 in FY2023, #94 in FY2024 and not on the FY2025 list; up 2 since FY2020.
38 $39,829,252
Rank history: #67 in FY2022 and not on the FY2023–FY2025 lists; up 8 since FY2020.
39 $34,953,404
Rank history: not on the FY2022–FY2023 lists, #40 in FY2024 and #79 in FY2025; new, not ranked in FY2020.
40 $32,736,607
Rank history: #32 in FY2022, #9 in FY2023 and not on the FY2024–FY2025 lists; down 24 since FY2020.
41 $30,942,363
Rank history: #38 in FY2022, #49 in FY2023, #51 in FY2024 and #89 in FY2025; down 5 since FY2020.
42 $29,634,520
Rank history: not on the FY2022 list, #62 in FY2023, #18 in FY2024 and #10 in FY2025; down 22 since FY2020.
43 $28,397,992
Rank history: #26 in FY2022, #34 in FY2023 and not on the FY2024–FY2025 lists; up 17 since FY2020.
44 $27,868,987
Rank history: #88 in FY2022 and not on the FY2023–FY2025 lists; down 1 since FY2020.
45 $27,542,632
Rank history: #42 in FY2022, #39 in FY2023 and not on the FY2024–FY2025 lists; down 18 since FY2020.
46 $25,499,095
Rank history: #44 in FY2022, #38 in FY2023, #41 in FY2024 and #34 in FY2025; up 16 since FY2020.
47 $24,853,958
Rank history: #52 in FY2022, #69 in FY2023, #8 in FY2024 and #5 in FY2025; up 56 since FY2020.
48 $24,522,685
Rank history: #54 in FY2022, #51 in FY2023, #62 in FY2024 and not on the FY2025 list; down 24 since FY2020.
49 $24,424,137
Rank history: #9 in FY2022, #19 in FY2023, #59 in FY2024 and not on the FY2025 list; up 6 since FY2020.
50 $23,855,151
Rank history: #49 in FY2022 and not on the FY2023–FY2025 lists; down 39 since FY2020.
51 $22,501,800
Rank history: not on the FY2022–FY2024 lists and #41 in FY2025; up 32 since FY2020.
52 $22,035,318
Rank history: not on the FY2022 list, #77 in FY2023 and not on the FY2024–FY2025 lists; new, not ranked in FY2020.
53 $21,000,000
Rank history: not on the FY2022–FY2025 lists; up 393 since FY2020.
54 $20,823,658
Rank history: #48 in FY2022, #36 in FY2023, #99 in FY2024 and not on the FY2025 list; unchanged since FY2020.
55 $19,938,662
Rank history: #59 in FY2022, #63 in FY2023 and not on the FY2024–FY2025 lists; down 17 since FY2020.
56 $19,701,071
Rank history: #45 in FY2022 and not on the FY2023–FY2025 lists; up 8 since FY2020.
57
BAE Systems Land & Armaments L.P. Through BAE Systems Ordnance Systems Inc.
$19,600,196
Rank history: not on the FY2022–FY2025 lists; new, not ranked in FY2020.
58 $19,573,316
Rank history: #87 in FY2022, #67 in FY2023, #85 in FY2024 and not on the FY2025 list; up 104 since FY2020.
59 $19,266,857
Rank history: #60 in FY2022 and not on the FY2023–FY2025 lists; down 30 since FY2020.
60 $18,935,188
Rank history: #23 in FY2022 and not on the FY2023–FY2025 lists; down 34 since FY2020.
61 $18,238,809
Rank history: not on the FY2022 list, #74 in FY2023, #48 in FY2024 and #59 in FY2025; up 23 since FY2020.
62 $15,508,890
Rank history: #57 in FY2022, #57 in FY2023, not on the FY2024 list and #78 in FY2025; down 4 since FY2020.
63 $15,295,475
Rank history: not on the FY2022–FY2025 lists; up 363 since FY2020.
64 $14,652,640
Rank history: #72 in FY2022, #55 in FY2023 and not on the FY2024–FY2025 lists; down 34 since FY2020.
65 $14,500,000
Rank history: not on the FY2022–FY2025 lists; new, not ranked in FY2020.
66 $13,812,977
Rank history: not on the FY2022–FY2025 lists; down 29 since FY2020.
67 $13,743,102
Rank history: #69 in FY2022, #94 in FY2023, #79 in FY2024 and not on the FY2025 list; up 41 since FY2020.
68 $13,476,004
Rank history: #100 in FY2022 and not on the FY2023–FY2025 lists; down 11 since FY2020.
69 $13,227,522
Rank history: not on the FY2022–FY2025 lists; up 6 since FY2020.
70 $13,208,888
Rank history: not on the FY2022 list, #71 in FY2023, not on the FY2024 list and #64 in FY2025; down 22 since FY2020.
71 $12,528,000
Rank history: #41 in FY2022, #70 in FY2023 and not on the FY2024–FY2025 lists; new, not ranked in FY2020.
72 $12,088,985
Rank history: #99 in FY2022 and not on the FY2023–FY2025 lists; up 29 since FY2020.
73 $11,549,222
Rank history: #78 in FY2022, #82 in FY2023, #72 in FY2024 and #54 in FY2025; up 8 since FY2020.
74 $11,039,753
Rank history: #63 in FY2022, #46 in FY2023, #70 in FY2024 and #92 in FY2025; down 1 since FY2020.
75 $10,528,442
Rank history: not on the FY2022–FY2025 lists; up 37 since FY2020.
76 $10,258,618
Rank history: not on the FY2022–FY2025 lists; up 236 since FY2020.
77 $10,000,000
Rank history: not on the FY2022–FY2025 lists; down 60 since FY2020.
78 $9,885,816
Rank history: not on the FY2022 list, #47 in FY2023 and not on the FY2024–FY2025 lists; new, not ranked in FY2020.
79 $9,702,298
Rank history: not on the FY2022 list, #45 in FY2023 and not on the FY2024–FY2025 lists; new, not ranked in FY2020.
80 $9,684,586
Rank history: #82 in FY2022, #65 in FY2023 and not on the FY2024–FY2025 lists; down 1 since FY2020.
81 $9,593,153
Rank history: #75 in FY2022, #59 in FY2023 and not on the FY2024–FY2025 lists; new, not ranked in FY2020.
82 $9,216,114
Rank history: #95 in FY2022, #92 in FY2023, #97 in FY2024 and not on the FY2025 list; up 6 since FY2020.
83 $8,344,855
Rank history: not on the FY2022 list, #68 in FY2023, #98 in FY2024 and not on the FY2025 list; down 51 since FY2020.
84
Mylan Pharmaceuticals Inc. 2 awardees, including Mylan Specialty LP
$8,250,000
Rank history: not on the FY2022–FY2025 lists; new, not ranked in FY2020.
85 $8,165,449
Rank history: #11 in FY2022, #93 in FY2023, #91 in FY2024 and not on the FY2025 list; up 19 since FY2020.
86 $8,129,529
Rank history: not on the FY2022–FY2025 lists; up 58 since FY2020.
87 $8,069,045
Rank history: not on the FY2022–FY2025 lists; down 31 since FY2020.
88 $7,882,656
Rank history: #83 in FY2022, #72 in FY2023, #93 in FY2024 and not on the FY2025 list; down 37 since FY2020.
89 $7,658,421
Rank history: #65 in FY2022, #85 in FY2023, #90 in FY2024 and not on the FY2025 list; up 8 since FY2020.
90 $7,541,658
Rank history: #64 in FY2022 and not on the FY2023–FY2025 lists; up 125 since FY2020.
91 $7,479,207
Rank history: #93 in FY2022, #54 in FY2023, #44 in FY2024 and not on the FY2025 list; up 54 since FY2020.
92 $7,217,854
Rank history: #86 in FY2022, #78 in FY2023, #80 in FY2024 and #82 in FY2025; down 21 since FY2020.
93
Cobham Advanced Electronic Solutions Inc. 3 awardees, including Mission Systems Davenport Inc. and Cobham Exeter, Inc.
$7,109,243
Rank history: not on the FY2022–FY2025 lists; down 1 since FY2020.
94 $6,932,000
Rank history: #85 in FY2022, not on the FY2023 list, #58 in FY2024 and not on the FY2025 list; down 4 since FY2020.
95
Catalent Indiana LLC
$6,640,000
Rank history: not on the FY2022–FY2025 lists; up 95 since FY2020.
96 $6,378,856
Rank history: not on the FY2022–FY2025 lists; up 20 since FY2020.
97 $6,253,710
Rank history: not on the FY2022–FY2025 lists; up 39 since FY2020.
98 $6,000,000
Rank history: #96 in FY2022, #81 in FY2023 and not on the FY2024–FY2025 lists; up 41 since FY2020.
99 $5,985,961
Rank history: #84 in FY2022 and not on the FY2023–FY2025 lists; up 36 since FY2020.
100
Pyrotechnique by Grucci Inc
$5,919,408
Rank history: #70 in FY2022, #86 in FY2023 and not on the FY2024–FY2025 lists; down 28 since FY2020.
Show 75 more

100 of 2,234 contractors listed here. See the rest on GovTribe.

Rankings for the codes under NAICS 325

Code Net obligations Largest contractor
3254 Pharmaceutical and Medicine Manufacturing $55,780,216,011 Pfizer Inc.
3259 Other Chemical Product and Preparation Manufacturing $831,840,505 Chemring Group PLC
3251 Basic Chemical Manufacturing $349,507,398 Mid-America Conversion Services, LLC
3252 Resin, Synthetic Rubber, and Artificial and Synthetic Fibers and Filaments Manufacturing $279,701,393 Rhino Health, Inc.
3255 Paint, Coating, and Adhesive Manufacturing $80,670,000 Science Applications International Corporation
3253 Pesticide, Fertilizer, and Other Agricultural Chemical Manufacturing $39,306,887 Perimeter Solutions LP
3256 Soap, Cleaning Compound, and Toilet Preparation Manufacturing $33,630,952 Rite-Kem, Inc.

How this ranking works

  • Source: every contract action FPDS records (as published on SAM.gov) in the period, as GovTribe received it.
  • Amounts are net obligations: what was obligated, less what was deobligated. Shares are of $58.5 billion obligated before deobligations, so they never pass 100%.
  • Parent companies: each action counts under the ultimate parent its award record names, or under the awardee when it names none, so no dollar counts twice. Parents of the same name (Inc., LLC and the like aside) count as one company, since FPDS records a company's parent under more than one UEI over time. GovTribe corrects a few parents and names by hand; see the corrections.
  • Fiscal year 2021 ran Oct 1, 2020 – Sep 30, 2021. The Department of Defense reports its contract actions to FPDS about 90 days late, so a fiscal year is ranked once they're in, in February, and the list doesn't change after.
  • Rank changes compare with FY2020. "New" marks a company outside that period's top 500, and "Returned" one of those that was on an earlier fiscal year's list.
  • Rank lines show each company's rank on every fiscal year's list since FY2021, #1 at the top, on a scale that gives the top of the list more room. A dashed stretch spans years it wasn't on the list. The step from FY2020 takes the color of the rank change beside it.
  • Placeholder recipients FPDS uses when it names no company ("Miscellaneous Foreign Contractors" and the like) aren't ranked.

Quick answers

Who were the top 10 NAICS 325 contractors in FY2021?

1. Pfizer Inc. ($23.1B), 2. Mckesson Corporation ($11.7B), 3. Modernatx Inc. ($7.36B), 4. Regeneron Pharmaceuticals Inc. ($5.57B), 5. ELI Lilly and Company ($1.91B), 6. Abbott Laboratories ($1.66B), 7. Merck & Co. Inc. ($1.31B), 8. Cencora, Inc. ($516M), 9. Glaxosmithkline LLC ($288M), 10. Emergent Biosolutions Inc. ($257M).

On GovTribe

Research every contractor on this list

  • Every contract, task order and IDV they hold
  • Their subsidiaries, teammates and competitors
  • Open opportunities they're positioned for
  • Alerts when they win new work